Neuberger Berman Group
BHVN icon

Neuberger Berman Group’s Biohaven BHVN Stock Holding History

Neuberger Berman Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-129,465
Closed -$4.84M – 1983
2024
Q4 		$4.84M Buy
129,465
+125,225
+2,953% +$5.84M ﹤0.01% 969
2024
Q3 		$212K Buy
+4,240
New +$165K ﹤0.01% 1781

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Neuberger Berman Group's BHVN Position: Q1 2025 in Review

Neuberger Berman Group sold out of Biohaven (BHVN) in Q1 2025, closing a stake of 129,465 shares — an estimated $4.84M sold.

Neuberger Berman Group first reported a position in BHVN in Q3 2024 and held it in 2 quarters. The position peaked at $4.84M in Q4 2024. 266 funds tracked by Wall St. Rank hold BHVN as of Q1 2025.

  • Neuberger Berman Group reported no remaining Biohaven position as of Q1 2025 after selling out during the quarter.
  • Neuberger Berman Group sold 129,465 Biohaven shares in Q1 2025, an estimated $4.84M.
  • Neuberger Berman Group first reported a position in Biohaven in Q3 2024 and held it in 2 quarters.
  • Neuberger Berman Group's Biohaven position peaked at $4.84M in Q4 2024.
  • 266 funds tracked by Wall St. Rank held Biohaven as of Q1 2025.

Based on Neuberger Berman Group's 13F filing for Q1 2025, filed 13 May 2025.